rs142537392
Variant summary
Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2
The NM_006514.4(SCN10A):c.4762C>T(p.Arg1588*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000149 in 1,614,062 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. R1588R) has been classified as Likely benign.
Frequency
Consequence
NM_006514.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- sodium channelopathy-related small fiber neuropathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- episodic pain syndrome, familial, 2Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- Brugada syndromeInheritance: Unknown Classification: LIMITED Submitted by: Genomics England PanelApp
- Brugada syndrome 1Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -5 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SCN10A | ENST00000449082.3 | c.4762C>T | p.Arg1588* | stop_gained | Exon 28 of 28 | 1 | NM_006514.4 | ENSP00000390600.2 | ||
| SCN10A | ENST00000643924.1 | c.4759C>T | p.Arg1587* | stop_gained | Exon 27 of 27 | ENSP00000495595.1 | ||||
| SCN10A | ENST00000655275.1 | c.4786C>T | p.Arg1596* | stop_gained | Exon 28 of 28 | ENSP00000499510.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152174Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 10AN: 251224 AF XY: 0.0000516 show subpopulations
GnomAD4 exome AF: 0.0000144 AC: 21AN: 1461888Hom.: 0 Cov.: 35 AF XY: 0.0000179 AC XY: 13AN XY: 727246 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152174Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1AN XY: 74340 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:1
The R1588X variant has not been published as a pathogenic variant, but it has been reported as heterozygous in one healthy control individual (Le Scouarnec et al., 2015). Additionally, the R1588X variant is observed in 8/18862 (0.04%) alleles from individuals of East Asian background in large population cohorts (Lek et al., 2016). This variant is predicted to cause loss of normal protein function through protein truncation as the last 369 amino acids of the protein are absent due to the introduction of a premature termination codon in the 3'-terminal exon. However, no downstream nonsense or truncation variants have been reported in the Human Genome Mutation Database (HGMD), and the vast majority of pathogenic variants reported in SCN10A are missense substitutions (Stenson et al., 2014). Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at